Browsing by Subject "Waldenström macroglobulinemia"

Now showing items 1-1 of 1

Multicenter Phase 2 Trial of Rituximab for Waldenström Macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98)

Gertz, Morie A.; Rué i Monné, Montserrat; Blood, Emily; Kaminer, Lynne S.; Vesole, David H.; Greipp, Philip R. (Taylor & Francis, 2004)

Waldenström macroglobulinemia (WM) is a low-grade lymphoplasmacytic lymphoma that strongly expresses CD20 on the cell surface. This study was undertaken to determine the response rate of patients with untreated or ...